Herb C. Cross to Join KaloBios as Chief Financial Officer
September 19, 2013 at 16:05 PM EDT
KaloBios Pharmaceuticals (Nasdaq: KBIO ) today announced that Herb C. Cross will join the company as of September 23, 2013, and transition into the Chief Financial Officer role in coordination with Jeffrey H. Cooper, the company's current CFO. The company expects this transition will be completed in the
